CSIMarket
 
Elutia Inc   (NASDAQ: ELUT)
 

Elutia Inc's Suppliers Performance

ELUT's Supply Chain




 
ELUT Costs vs Sales of Suppliers Growth Elutia Inc's cost of sales deteriorated by -67.33 % year on year, relative to one quarter ago cost of sales fell by -2 % in Q2.

More on ELUT Suppliers



Elutia Inc's cost of sales deteriorated by -67.33 % year on year, compare to one quarter ago cost of sales fell by -2 % in Q2.

More on ELUT Suppliers




Elutia Inc's Comment on Supply Chain


The company depends on a limited number of suppliers for raw materials, including Cook, the sole supplier of the SIS ECM biomaterial used in its Cardiovascular products. After selling its Orthobiologics Business to Berkeley in November 2023, the company ceased operations at its Richmond, California tissue processing facility but continues a contract manufacturing relationship with Berkeley, which remains the exclusive source for SimpliDerm. The company requires suppliers to deliver products in substantial quantities that comply with regulatory requirements, specifications, cost parameters, and delivery schedules. Potential risks include manufacturing disruptions, regulatory limitations on qualifying new suppliers, and reliance on sole-source suppliers. Transitioning to new suppliers may involve significant effort, investment, and regulatory approvals, which could lead to operational interruptions and financial consequences.

Elutia Inc's Comment on Supply Chain


The company depends on a limited number of suppliers for raw materials, including Cook, the sole supplier of the SIS ECM biomaterial used in its Cardiovascular products. After selling its Orthobiologics Business to Berkeley in November 2023, the company ceased operations at its Richmond, California tissue processing facility but continues a contract manufacturing relationship with Berkeley, which remains the exclusive source for SimpliDerm. The company requires suppliers to deliver products in substantial quantities that comply with regulatory requirements, specifications, cost parameters, and delivery schedules. Potential risks include manufacturing disruptions, regulatory limitations on qualifying new suppliers, and reliance on sole-source suppliers. Transitioning to new suppliers may involve significant effort, investment, and regulatory approvals, which could lead to operational interruptions and financial consequences.







ELUT's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Elutia Inc 38.21 13.49 49.84 26
SUBTOTAL 0.00 0.00 0.00 -


Sources: Elutia Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Elutia Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.